Anzeige
Mehr »
Mittwoch, 22.04.2026 - Börsentäglich über 12.000 News
BREAKING: Pacifica liefert hochgradige Treffer - Phase II trifft genau ins Ziel
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von FierceBiotech

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
17.03.J&J changes New York state of mind, closing JLABS site after 8 years
17.03.Hitting regulatory roadblock, Bicycle pumps brakes on lead program and deflates headcount by 30%
17.03.FDA rejects Aldeyra dry eye disease drug for 3rd time, citing inconsistent study findings
17.03.Pfizer's hotly tipped breast cancer prospect delivers phase 2 win
16.03.Roche inks Nvidia deal to bolster AI factory, speed up drug and diagnostic development
16.03.Astellas walks away from $1.6B biobucks T-cell engager pact with CytomX after 6 years
16.03.Structure touts 16% weight loss for aleniglipron as 'highest efficacy' for an oral GLP-1 yet
13.03.Sana sees 14-month insulin production for transplanted islet therapy in single Type 1 diabetes patient
13.03.Inovio trims team as trouble brews at FDA for rare disease candidate
13.03.Immutep's phase 3 failure for immunotherapy surprises analysts, sinks stock
12.03.Stop Asking for an AI strategy: 3 questions clinical leaders should ask instead
12.03.Pfizer Ignite, designed to accelerate promising biotech therapies, fizzles out
12.03.Vistagen lays off 20% of staff to tighten focus on struggling social anxiety candidate
12.03.Ultragenyx gene therapy hits co-primary endpoint in phase 3 rare disease study, teeing up potential win
12.03.Small molecules are 'resurgent' in orphan drug R&D: Evaluate
12.03.BridgeBio's muscle weakness data impress ahead of FDA filing
12.03.Novo Holdings sees assets shrink by a 3rd in wake of Novo Nordisk's nosediving share price
12.03.Regenxbio posts clean safety profile for DMD gene therapy as pivotal data loom
11.03.Evotec reveals sweeping 800-person layoffs, more site closures as restructuring rolls on
11.03.CNS Pharma wipes glioblastoma pipeline clean in strategic pivot to fresh neurology, oncology targets
11.03.Salspera plans $91M IPO to fund phase 3 studies of salmonella-based cancer therapy
10.03.Molecular glue biotech shutters after 'brutal' few years for early-stage companies
10.03.Lilly pledges $500M to South Korea biopharma industry, following Roche's lead
10.03.FDA reconsidering Capricor's snubbed DMD cell therapy after 'lifting' rejection
10.03.Republican senator slams FDA rare disease rebuffs, pledges to investigate recent actions: Bloomberg